Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

68Ga-PSMA-11 dose reduction for dedicated pelvic imaging with simultaneous PET/MR using TOF BSREM reconstructions.

Svirydenka H, Muehlematter UJ, Nagel HW, Delso G, Ferraro DA, Kudura K, Burger IA, Ter Voert EEGW.

Eur Radiol. 2020 Feb 14. doi: 10.1007/s00330-020-06667-2. [Epub ahead of print]

PMID:
32060711
2.
3.

[Advances in Oncology 2019].

Vernadou A, Ferahta N, Mederos N, Ferraro D, Dischl-Antonioni I, Diciolla A, Liapi A, Mosimann V, Latifyan S, Aedo-Lopez V, Berthold D, Digklia A, Michielin O, Montemurro M, Wagner AD, Zaman K, Peters S, Stravodimou A, Sarivalasis A.

Rev Med Suisse. 2020 Jan 15;16(676-7):72-77. Review. French.

PMID:
31961089
4.

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder.

Kunchok A, Malpas C, Nytrova P, Havrdova EK, Alroughani R, Terzi M, Yamout B, Hor JY, Karabudak R, Boz C, Ozakbas S, Olascoaga J, Simo M, Granella F, Patti F, McCombe P, Csepany T, Singhal B, Bergamaschi R, Fragoso Y, Al-Harbi T, Turkoglu R, Lechner-Scott J, Laureys G, Oreja-Guevara C, Pucci E, Sola P, Ferraro D, Altintas A, Soysal A, Vucic S, Grand'Maison F, Izquierdo G, Eichau S, Lugaresi A, Onofrj M, Trojano M, Marriott M, Butzkueven H, Kister I, Kalincik T.

Mult Scler Relat Disord. 2019 Nov 25;38:101868. doi: 10.1016/j.msard.2019.101868. [Epub ahead of print]

PMID:
31877445
5.

Abnormal Circadian Modification of Aδ-Fiber Pathway Excitability in Idiopathic Restless Legs Syndrome.

Vollono C, Della Marca G, Testani E, Losurdo A, Virdis D, Ferraro D, Brunetti V, Rossini PM, Le Pera D, Mazza S, Valeriani M.

Pain Res Manag. 2019 Nov 3;2019:5408732. doi: 10.1155/2019/5408732. eCollection 2019.

6.

Artificial intelligence for detecting small FDG-positive lung nodules in digital PET/CT: impact of image reconstructions on diagnostic performance.

Schwyzer M, Martini K, Benz DC, Burger IA, Ferraro DA, Kudura K, Treyer V, von Schulthess GK, Kaufmann PA, Huellner MW, Messerli M.

Eur Radiol. 2019 Dec 10. doi: 10.1007/s00330-019-06498-w. [Epub ahead of print]

PMID:
31822970
7.

Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer.

Ferraro DA, Garcia Schüler HI, Muehlematter UJ, Eberli D, Müller J, Müller A, Gablinger R, Kranzbühler H, Omlin A, Kaufmann PA, Hermanns T, Burger IA.

Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):652-664. doi: 10.1007/s00259-019-04568-1. Epub 2019 Dec 4.

PMID:
31802175
8.

Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis.

Nasi M, Bianchini E, De Biasi S, Gibellini L, Neroni A, Mattioli M, Pinti M, Iannone A, Mattioli AV, Simone AM, Ferraro D, Vitetta F, Sola P, Cossarizza A.

J Neuroimmunol. 2020 Jan 15;338:577107. doi: 10.1016/j.jneuroim.2019.577107. Epub 2019 Nov 7.

PMID:
31726376
9.

Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.

Ferraro D, Trovati A, Bedin R, Natali P, Franciotta D, Santangelo M, Camera V, Vitetta F, Varani M, Trenti T, Gastaldi M, De Biasi S, Nasi M, Pinti M, Meletti S, Sola P.

Eur J Neurol. 2020 Mar;27(3):461-467. doi: 10.1111/ene.14121. Epub 2019 Dec 2.

PMID:
31710409
10.

Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study.

Ferraro D, Annovazzi P, Moccia M, Lanzillo R, De Luca G, Nociti V, Fantozzi R, Paolicelli D, Ragonese P, Gajofatto A, Boffa L, Cavalla P, Lo Fermo S, Buscarinu MC, Lorefice L, Cordioli C, Calabrese M, Gallo A, Pinardi F, Tortorella C, Di Filippo M, Camera V, Maniscalco GT, Radaelli M, Buttari F, Tomassini V, Cocco E, Gasperini C, Solaro C; RIREMS (Rising Researchers in Multiple Sclerosis).

Mult Scler Relat Disord. 2019 Oct 19;37:101461. doi: 10.1016/j.msard.2019.101461. [Epub ahead of print]

PMID:
31678859
11.

68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer.

Ferraro DA, Muehlematter UJ, Garcia Schüler HI, Rupp NJ, Huellner M, Messerli M, Rüschoff JH, Ter Voert EEGW, Hermanns T, Burger IA.

Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):147-159. doi: 10.1007/s00259-019-04511-4. Epub 2019 Sep 14.

PMID:
31522272
12.

Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.

Solari A, Giovannetti AM, Giordano A, Tortorella C, Torri Clerici V, Brichetto G, Granella F, Lugaresi A, Patti F, Salvetti M, Pesci I, Pucci E, Centonze D, Danni MC, Bonavita S, Ferraro D, Gallo A, Gajofatto A, Nociti V, Grimaldi L, Grobberio M, Lanzillo R, Di Giovanni R, Gregori S, Manni A, Pietrolongo E, Bertagnoli S, Ronzoni M, Compagnucci L, Fantozzi R, Allegri B, Arena S, Buscarinu MC, Sabattini L, Quartuccio ME, Tsantes E, Confaloneri P, Tacchino A, Schiffmann I, Rahn AC, Kleiter I, Messmer Uccelli M, Barabasch A, Heesen C, The ManTra Project.

Front Neurol. 2019 Aug 22;10:916. doi: 10.3389/fneur.2019.00916. eCollection 2019.

13.

Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study).

Calvaruso V, Bronte F, Ferraro D, Reina G, Conte E, Rini F, Magro B, Petta S, Di Marco V, Craxì A.

Liver Int. 2019 Dec;39(12):2240-2243. doi: 10.1111/liv.14242. Epub 2019 Sep 20.

PMID:
31502755
14.

Risk of secondary progressive multiple sclerosis: A longitudinal study.

Fambiatos A, Jokubaitis V, Horakova D, Kubala Havrdova E, Trojano M, Prat A, Girard M, Duquette P, Lugaresi A, Izquierdo G, Grand'Maison F, Grammond P, Sola P, Ferraro D, Alroughani R, Terzi M, Hupperts R, Boz C, Lechner-Scott J, Pucci E, Bergamaschi R, Van Pesch V, Ozakbas S, Granella F, Turkoglu R, Iuliano G, Spitaleri D, McCombe P, Solaro C, Slee M, Ampapa R, Soysal A, Petersen T, Sanchez-Menoyo JL, Verheul F, Prevost J, Sidhom Y, Van Wijmeersch B, Vucic S, Cristiano E, Saladino ML, Deri N, Barnett M, Olascoaga J, Moore F, Skibina O, Gray O, Fragoso Y, Yamout B, Shaw C, Singhal B, Shuey N, Hodgkinson S, Altintas A, Al-Harbi T, Csepany T, Taylor B, Hughes J, Jun JK, van der Walt A, Spelman T, Butzkueven H, Kalincik T.

Mult Scler. 2020 Jan;26(1):79-90. doi: 10.1177/1352458519868990. Epub 2019 Aug 9.

PMID:
31397221
15.

Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.

De Biasi S, Simone AM, Bianchini E, Lo Tartaro D, Pecorini S, Nasi M, Patergnani S, Carnevale G, Gibellini L, Ferraro D, Vitetta F, Pinton P, Sola P, Cossarizza A, Pinti M.

Eur J Immunol. 2019 Dec;49(12):2204-2221. doi: 10.1002/eji.201948223. Epub 2019 Aug 16.

PMID:
31373677
16.

Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients.

Ferraro D, Guicciardi C, De Biasi S, Pinti M, Bedin R, Camera V, Vitetta F, Nasi M, Meletti S, Sola P.

Acta Neurol Scand. 2020 Jan;141(1):16-21. doi: 10.1111/ane.13152. Epub 2019 Aug 26.

PMID:
31350854
17.

The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study.

Curti E, Tsantes E, Baldi E, Caniatti LM, Ferraro D, Sola P, Granella F.

Mult Scler Relat Disord. 2019 Aug;33:146-152. doi: 10.1016/j.msard.2019.05.026. Epub 2019 May 31.

PMID:
31200271
18.

Characteristics of Chronic Pain among Head and Neck Cancer Patients Treated with Radiation Therapy: A Retrospective Study.

Kallurkar A, Kulkarni S, Delfino K, Ferraro D, Rao K.

Pain Res Manag. 2019 May 6;2019:9675654. doi: 10.1155/2019/9675654. eCollection 2019.

19.

Aggravation and deliberation over lung herniation.

Lee MN, Surry LT, Ferraro DM.

BMJ Case Rep. 2019 May 27;12(5). pii: e229225. doi: 10.1136/bcr-2019-229225.

PMID:
31138594
20.

[Side effects of immune checkpoint inhibitors: diagnosis and management].

Perrinjaquet C, Zaher M, Ferraro DA, Comte D, Trueb L, Zimmermann S, Coukos G, Orcurto A.

Rev Med Suisse. 2019 May 15;15(651):1010-1016. French.

PMID:
31091034
21.

"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.

Calabrese M, Gasperini C, Tortorella C, Schiavi G, Frisullo G, Ragonese P, Fantozzi R, Prosperini L, Annovazzi P, Cordioli C, Di Filippo M, Ferraro D, Gajofatto A, Malucchi S, Lo Fermo S, De Luca G, Stromillo ML, Cocco E, Gallo A, Paolicelli D, Lanzillo R, Tomassini V, Pesci I, Rodegher ME, Solaro C; RIREMS group (Rising Italian Researchers in Multiple Sclerosis).

Neurology. 2019 May 28;92(22):e2527-e2537. doi: 10.1212/WNL.0000000000007573. Epub 2019 May 1.

22.

Sampling related individuals within ponds biases estimates of population structure in a pond-breeding amphibian.

O'Connell KA, Mulder KP, Maldonado J, Currie KL, Ferraro DM.

Ecol Evol. 2019 Mar 6;9(6):3620-3636. doi: 10.1002/ece3.4994. eCollection 2019 Mar.

23.

Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells.

Ferraro DA, Patella F, Zanivan S, Donato C, Aceto N, Giannotta M, Dejana E, Diepenbruck M, Christofori G, Buess M.

BMC Cancer. 2019 Apr 4;19(1):312. doi: 10.1186/s12885-019-5521-8.

24.

First Clinicopathologic Evidence of a Non-PSMA-Related Uptake Mechanism for 68Ga-PSMA-11 in Salivary Glands.

Rupp NJ, Umbricht CA, Pizzuto DA, Lenggenhager D, Töpfer A, Müller J, Muehlematter UJ, Ferraro DA, Messerli M, Morand GB, Huber GF, Eberli D, Schibli R, Müller C, Burger IA.

J Nucl Med. 2019 Sep;60(9):1270-1276. doi: 10.2967/jnumed.118.222307. Epub 2019 Feb 8.

PMID:
30737300
25.

68Ga-PSMA-11 PET/MR Can Be False Positive in Normal Prostatic Tissue.

Ferraro DA, Rupp NJ, Donati OF, Messerli M, Eberli D, Burger IA.

Clin Nucl Med. 2019 Apr;44(4):e291-e293. doi: 10.1097/RLU.0000000000002473.

PMID:
30688746
26.

68Ga-PSMA-11 PET/MR Detects Local Recurrence Occult on mpMRI in Prostate Cancer Patients After HIFU.

Burger IA, Müller J, Donati OF, Ferraro DA, Messerli M, Kranzbühler B, Ter Voert EEGW, Muehlematter UJ, Rupp NJ, Mortezavi A, Eberli D.

J Nucl Med. 2019 Aug;60(8):1118-1123. doi: 10.2967/jnumed.118.221564. Epub 2019 Jan 25.

PMID:
30683764
27.

Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma.

Messerli M, Kotasidis F, Burger IA, Ferraro DA, Muehlematter UJ, Weyermann C, Kenkel D, von Schulthess GK, Kaufmann PA, Huellner MW.

Br J Radiol. 2019 Apr;92(1096):20180792. doi: 10.1259/bjr.20180792. Epub 2019 Feb 26.

PMID:
30673302
28.

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.

Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, Van Pesch V, Sola P, Ferraro D, Grand'Maison F, Terzi M, Lechner-Scott J, Flechter S, Slee M, Shaygannejad V, Pucci E, Granella F, Jokubaitis V, Willis M, Rice C, Scolding N, Wilkins A, Pearson OR, Ziemssen T, Hutchinson M, Harding K, Jones J, McGuigan C, Butzkueven H, Kalincik T, Robertson N; MSBase Study Group.

JAMA. 2019 Jan 15;321(2):175-187. doi: 10.1001/jama.2018.20588.

29.

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.

Kalincik T, Kubala Havrdova E, Horakova D, Izquierdo G, Prat A, Girard M, Duquette P, Grammond P, Onofrj M, Lugaresi A, Ozakbas S, Kappos L, Kuhle J, Terzi M, Lechner-Scott J, Boz C, Grand'Maison F, Prevost J, Sola P, Ferraro D, Granella F, Trojano M, Bergamaschi R, Pucci E, Turkoglu R, McCombe PA, Pesch VV, Van Wijmeersch B, Solaro C, Ramo-Tello C, Slee M, Alroughani R, Yamout B, Shaygannejad V, Spitaleri D, Sánchez-Menoyo JL, Ampapa R, Hodgkinson S, Karabudak R, Butler E, Vucic S, Jokubaitis V, Spelman T, Butzkueven H.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):458-468. doi: 10.1136/jnnp-2018-319831. Epub 2019 Jan 13.

PMID:
30636699
30.

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study.

Nguyen AL, Havrdova EK, Horakova D, Izquierdo G, Kalincik T, van der Walt A, Terzi M, Alroughani R, Duquette P, Girard M, Prat A, Boz C, Sola P, Ferraro D, Lugaresi A, Lechner-Scott J, Barnett M, Grand'Maison F, Grammond P, Ramo-Tello C, Turkoglu R, McCombe P, Pucci E, Trojano M, Granella F, Spitaleri D, Van Pesch V, Soysal A, Oreja-Guevara C, Verheul F, Vucic S, Hodgkinson S, Slee M, Ampapa R, Prevost J, Menoyo JLS, Skibina O, Solaro C, Olascoaga J, Shaw C, Madsen KG, Naidoo K, Hyde R, Butzkueven H, Jokubaitis V; MSBase Study Group.

Mult Scler Relat Disord. 2019 Feb;28:235-243. doi: 10.1016/j.msard.2019.01.003. Epub 2019 Jan 3.

PMID:
30623864
31.

Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results.

Schwyzer M, Ferraro DA, Muehlematter UJ, Curioni-Fontecedro A, Huellner MW, von Schulthess GK, Kaufmann PA, Burger IA, Messerli M.

Lung Cancer. 2018 Dec;126:170-173. doi: 10.1016/j.lungcan.2018.11.001. Epub 2018 Nov 3.

PMID:
30527183
32.

Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction.

Müller J, Ferraro DA, Muehlematter UJ, Garcia Schüler HI, Kedzia S, Eberli D, Guckenberger M, Kroeze SGC, Sulser T, Schmid DM, Omlin A, Müller A, Zilli T, John H, Kranzbuehler H, Kaufmann PA, von Schulthess GK, Burger IA.

Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):889-900. doi: 10.1007/s00259-018-4203-0. Epub 2018 Nov 28.

PMID:
30488099
33.

Controlling the distance of highly confined droplets in a capillary by interfacial tension for merging on-demand.

Ferraro D, Serra M, Filippi D, Zago L, Guglielmin E, Pierno M, Descroix S, Viovy JL, Mistura G.

Lab Chip. 2018 Dec 18;19(1):136-146. doi: 10.1039/c8lc01182f.

PMID:
30484796
34.

Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study.

Lorscheider J, Kuhle J, Izquierdo G, Lugaresi A, Havrdova E, Horakova D, Hupperts R, Duquette P, Girard M, Prat A, Grand'Maison F, Grammond P, Sola P, Ferraro D, Trojano M, Ramo-Tello C, Lechner-Scott J, Pucci E, Solaro C, Slee M, Van Pesch V, Sanchez Menoyo JL, van der Walt A, Butzkueven H, Kappos L, Kalincik T; MSBase Study Group.

Eur J Neurol. 2019 Feb;26(2):363-370. doi: 10.1111/ene.13824. Epub 2018 Nov 2.

PMID:
30298572
35.

The ALPPS procedure: hepatocellular carcinoma as a main indication. An Italian single-center experience.

Vennarecci G, Ferraro D, Tudisco A, Levi Sandri GB, Guglielmo N, Berardi G, Sperduti I, Ettorre GM.

Updates Surg. 2019 Mar;71(1):67-75. doi: 10.1007/s13304-018-0596-3. Epub 2018 Sep 25.

PMID:
30255436
36.

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy.

Kister I, Spelman T, Patti F, Duquette P, Trojano M, Izquierdo G, Lugaresi A, Grammond P, Sola P, Ferraro D, Grand'Maison F, Alroughani R, Terzi M, Boz C, Hupperts R, Lechner-Scott J, Kappos L, Pucci E, Hodgkinson S, Solaro C, Butzkueven H.

J Neurol Sci. 2018 Aug 15;391:72-76. doi: 10.1016/j.jns.2018.06.001. Epub 2018 Jun 2.

PMID:
30103975
37.

Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.

Hughes J, Jokubaitis V, Lugaresi A, Hupperts R, Izquierdo G, Prat A, Girard M, Duquette P, Grand'Maison F, Grammond P, Sola P, Ferraro D, Ramo-Tello C, Trojano M, Slee M, Shaygannejad V, Boz C, Lechner-Scott J, Van Pesch V, Pucci E, Solaro C, Verheul F, Terzi M, Granella F, Spitaleri D, Alroughani R, Jun JK, Fambiatos A, Van der Walt A, Butzkueven H, Kalincik T; MSBase Study Group.

JAMA Neurol. 2018 Nov 1;75(11):1407-1415. doi: 10.1001/jamaneurol.2018.2109.

38.

Acute intestinal ischaemia from a portal vein thrombosis in a young female smoker on an oral contraceptive.

Hunninghake J, Murray BP, Ferraro D, Gancayco J.

BMJ Case Rep. 2018 Aug 4;2018. pii: bcr-2018-225135. doi: 10.1136/bcr-2018-225135.

PMID:
30077981
39.

Active immunization status against measles, mumps, rubella, hepatitis B in internationally adopted children, surveyed at the university hospital of Palermo, Sicily.

Giordano D, Provenzano S, Santangelo OE, Piazza D, Ferraro D, Colomba C, Corsello G, La Placa S, Firenze A.

Ann Ig. 2018 Sep-Oct;30(5):431-435. doi: 10.7416/ai.2018.2243.

40.

Dynamics of Ferrofluid Drops on Magnetically Patterned Surfaces.

Rigoni C, Ferraro D, Carlassara M, Filippi D, Varagnolo S, Pierno M, Talbot D, Abou-Hassan A, Mistura G.

Langmuir. 2018 Jul 31;34(30):8917-8922. doi: 10.1021/acs.langmuir.8b01520. Epub 2018 Jul 18.

PMID:
29969901
41.

Effects of Experimental Anthropogenic Noise Exposure on the Reproductive Success of Secondary Cavity Nesting Birds.

Mulholland TI, Ferraro DM, Boland KC, Ivey KN, Le ML, LaRiccia CA, Vigianelli JM, Francis CD.

Integr Comp Biol. 2018 Nov 1;58(5):967-976. doi: 10.1093/icb/icy079.

PMID:
29945170
42.

What's in a Rash? Viral Exanthem Versus CBRNE Exposure: Teleconsultation Support for Two Special Forces Soldiers With Diffuse Rash in an Austere Environment.

Lee HD, Butterfield S, Maddry J, Powell D, Vasios WN 3rd, Yun H, Ferraro D, Pamplin JC.

J Spec Oper Med. Summer 2018;18(2):133-135.

PMID:
29889970
43.

Bone marrow uptake of 18F-fluorodeoxyglucose in Hodgkin lymphoma without bone involvement: comparison between patients with and without B symptoms.

do Vale RHB, Ferraro DA, Duarte PS, Carvalho G, Lima MS, Coura Filho GB, Sapienza MT, Buchpiguel CA.

Radiol Bras. 2018 Mar-Apr;51(2):76-80. doi: 10.1590/0100-3984.2016.0201.

44.

Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis.

Ferraro D, Camera V, Vitetta F, Zennaro M, Ciolli L, Nichelli PF, Sola P.

Neurology. 2018 May 1;90(18):852-854. doi: 10.1212/WNL.0000000000005417. Epub 2018 Mar 30. No abstract available.

PMID:
29602915
45.

High-Power Collective Charging of a Solid-State Quantum Battery.

Ferraro D, Campisi M, Andolina GM, Pellegrini V, Polini M.

Phys Rev Lett. 2018 Mar 16;120(11):117702. doi: 10.1103/PhysRevLett.120.117702.

PMID:
29601745
46.

Successful Orthotopic Liver Transplant for Diffuse Biliary Papillomatosis With Malignant Transformation: A Case Report With Long-Term Follow-Up.

Ferraro D, Levi Sandri GB, Vennarecci G, Santoro R, Colasanti M, Meniconi RL, Lepiane P, Ettorre GM.

Exp Clin Transplant. 2019 Dec;17(6):835-837. doi: 10.6002/ect.2017.0134. Epub 2018 Mar 9.

47.

First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence.

Ferraro D, Camera V, Baldi E, Vacchiano V, Curti E, Guareschi A, Malagù S, Montepietra S, Strumia S, Santangelo M, Caniatti L, Foschi M, Lugaresi A, Granella F, Pesci I, Motti L, Neri W, Immovilli P, Montanari E, Vitetta F, Simone AM, Sola P.

Curr Med Res Opin. 2018 Oct;34(10):1803-1807. doi: 10.1080/03007995.2018.1451311. Epub 2018 Apr 12.

PMID:
29526118
48.

How sensitive are temperate tadpoles to climate change? The use of thermal physiology and niche model tools to assess vulnerability.

Perotti MG, Bonino MF, Ferraro D, Cruz FB.

Zoology (Jena). 2018 Apr;127:95-105. doi: 10.1016/j.zool.2018.01.002. Epub 2018 Jan 31.

PMID:
29496379
49.

Bilateral Indwelling Pleural Catheters for Pleural Effusions Secondary to Nonmalignant Superior Vena Cava Obstruction.

Ferraro DM, French SK, Bell DG.

Ann Am Thorac Soc. 2018 Feb;15(2):258-262. doi: 10.1513/AnnalsATS.201708-645CC. No abstract available.

PMID:
29388816
50.

Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?

Frau J, Villar LM, Sardu C, Secci MA, Schirru L, Ferraro D, Coghe G, Lorefice L, Fenu G, Bedin R, Sola P, Marrosu MG, Cocco E.

J Neurol. 2018 Feb;265(2):424-430. doi: 10.1007/s00415-017-8716-4. Epub 2017 Dec 22.

PMID:
29273846

Supplemental Content

Loading ...
Support Center